iTrace Pharmaceutical Solutions Private Limited
iTrace Pharmaceutical Solutions is a USFDA-registered, ISO 9001:2015-certified contract analytical laboratory in Ambernath, India, providing specialized pharmaceutical testing services — including extractables and leachables, nitrosamines, genotoxic impurities, and glass delamination studies — to drug developers preparing global regulatory submissions.
- Company typePrivate
- Founded2020
- HeadquartersAmbernath, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What iTrace Pharmaceutical Solutions Private Limited does
iTrace Pharmaceutical Solutions Private Limited is a privately held, India-based contract analytical chemistry laboratory founded in September 2020 and headquartered in Ambernath, Maharashtra. The company serves pharmaceutical companies with specialized testing services that support regulatory submissions to global regulated markets, including the United States. Its service portfolio spans seven core lines: extractables and leachables testing, nitrosamines analysis, method development and validation, glass delamination studies, elemental impurity analysis, genotoxic impurities testing, and medical device analysis per ISO 10993-17 and 18.
The underlying technical platform is built around advanced analytical instrumentation including LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, and UV spectrophotometry, with all methods aligned to USP, EMEA, PQRI, BPOG, and ISO guidelines. The company holds USFDA registration (FEI No. 3018238790), ISO 9001:2015 certification, National FDA site approval, and MSME registration, with NABL accreditation in process. The team is described as one of the most experienced in the Indian market for extractables-leachables, nitrosamines, and genotoxic impurities work.
The business operates on a project-based, quote-driven professional services model. Revenue is generated per testing engagement rather than via subscriptions or platform licensing, with multi-year contracts possible on larger programs. Go-to-market is direct sales-led through the company website, business development email, and phone-based contact with a small team of approximately 11 employees. The company is vertically focused on pharmaceutical clients and currently serves the South Asia market, with USFDA registration positioning it to support submissions into US-regulated markets.
iTrace Pharmaceutical Solutions Private Limited firmographics
Firmographics- Name
- iTrace Pharmaceutical Solutions Private Limited
- Legal name
- i-Trace Pharmaceuticals Solutions Pvt. Ltd.
- Website
- https://itracepharma.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- iTrace Pharmaceutical Solutions is a USFDA-registered, ISO 9001:2015-certified contract analytical laboratory in Ambernath, India, providing specialized pharmaceutical testing services — including extractables and leachables, nitrosamines, genotoxic impurities, and glass delamination studies — to drug developers preparing global regulatory submissions.
- Ownership category
- akta.pro rank
iTrace Pharmaceutical Solutions Private Limited industry classification
Industry- Product category
- Pharmaceutical Analytical Testing Services
- NAICS
- Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Extractables & Leachables / Container-Closure Testing (HLAGADAI)
- akta.pro secondary industries
- Elemental Impurities & Trace Metals (ICP-MS) (HLAGADAJ), Method Development & Validation (ICH/USP) (HLAGADAB), Release Testing & Batch Certification (QC) (HLAGADAC), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
Keywords
Where iTrace Pharmaceutical Solutions Private Limited is headquartered
LocationHeadquarters
- HQ city
- Ambernath
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
iTrace Pharmaceutical Solutions Private Limited business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Laboratory Testing Services: Analytical chemistry testing services including extractables/leachables, nitrosamines, method development/validation, glass delamination, elemental impurity analysis, and genotoxic impurities testing for pharmaceutical companies
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom Laboratory Testing Services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
iTrace Pharmaceutical Solutions Private Limited product offering
Product offeringCore offering
iTrace Pharmaceutical Solutions operates an analytical chemistry testing laboratory serving pharmaceutical companies with specialized regulated studies. Its core offerings include extractables and leachables testing (per USP, PQRI, and BPOG), nitrosamines impurity analysis, method development and validation, glass delamination testing, elemental impurity analysis per USP 232/233, genotoxic impurity testing, medical device analysis per ISO 10993-17/18, and routine batch and stability testing. These services are delivered through advanced instrumentation (LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, UV) within a USFDA-registered, ISO 9001:2015-certified facility to support client submissions in regulated markets.
Product overview
iTrace Pharmaceutical Solutions Private Limited operates as an analytical testing laboratory providing a suite of specialized pharmaceutical testing services. The company's portfolio comprises seven distinct analytical service lines: Extractables and Leachable Testing (covering plastic, glass, and packaging analysis per USP, PQRI, and BPOG standards), Nitrosamines Testing, Method Development and Validation, Glass Delamination Testing, Elemental Impurity Analysis (per USP 232/233), Genotoxic Impurities Testing, and Medical Device Analysis (per ISO 10993-17 & 18). These services are supported by a range of analytical instrumentation including LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, and UV Spectrophotometry. The company functions as a single unified laboratory service rather than a modular software platform, delivering its services to pharmaceutical companies seeking regulatory compliance testing.
Differentiator
Problem solved
Functional benefit
Products and services
- Extractables and Leachable Testing Laboratory analysis of extractable and leachable compounds from pharmaceutical packaging and delivery systems, covering plastic, glass, and packaging analysis under USP, PQRI, and BPOG standards. Intended for pharmaceutical companies that must characterize packaging-related impurities to support regulatory submissions.
- Nitrosamines Testing Analysis and characterization of nitrosamine impurities in pharmaceutical products, addressing regulatory safety concerns and supporting product risk assessments and submissions.
- Method Development and Method Validation Custom analytical method development and validation services for pharmaceutical testing, supporting regulatory submissions, batch analysis, and stability studies.
- Glass Delamination Testing Laboratory analysis to detect and characterize glass delamination in pharmaceutical containers, ensuring container closure integrity and supporting container compatibility assessments.
- Elemental Impurity Analysis Determination of elemental impurities in pharmaceutical products as per USP 232 and 233 guidelines, ensuring compliance with safety thresholds and supporting regulatory submissions.
- Genotoxic Impurities Testing Identification and quantification of genotoxic impurities in pharmaceutical compounds to assess carcinogenic risk and ensure patient safety, supporting regulatory submissions.
- Medical Device Analysis Analytical testing of medical devices as per ISO 10993-17 and ISO 10993-18 standards, including toxicological assessment for medical device manufacturers.
- Routine Analysis and Batch Testing General pharmaceutical routine analysis and batch testing services supporting quality control across product lifecycle stages, including stability testing.
Companies that use iTrace Pharmaceutical Solutions Private Limited
Customer profileSegments1 record
Ideal customer profiles1 record
iTrace Pharmaceutical Solutions Private Limited technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
iTrace Pharmaceutical Solutions Private Limited partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights4 records
iTrace Pharmaceutical Solutions Private Limited competitors and assessment
Company assessmentBroad incumbents
- WuXi AppTec: Global CRO/CDMO with comprehensive pharmaceutical testing services including extractables/leachables and nitrosamines. Comparable offerings but operates at vastly greater scale and global footprint.
- Intertek: Global quality assurance provider with pharmaceutical services spanning analytical testing, method development, and regulatory support. Overlaps with iTrace's pharma testing offering but at multi-national scale.
- SGS: Global inspection, verification, testing and certification company with a Life Sciences division offering pharmaceutical analytical services including impurity testing. Comparable buyer/use case but far larger and broader in scope.
- Eurofins Scientific: Global testing services giant with extensive pharmaceutical analytical testing capability including extractables/leachables, nitrosamines, and elemental impurities. iTrace competes for the same pharma testing wallet share but operates as a niche specialist against Eurofins' broad portfolio.
Direct peers
- Anthem Biosciences: Bangalore-based CRO/CDMO offering analytical services, formulation development, and impurity testing for pharma clients. Direct comparable in the Indian pharma analytical testing market.
- Pace Analytical Services: US-based analytical testing laboratory network serving pharmaceutical clients with method development, validation, and impurity testing. Comparable as a specialized analytical services provider for regulated industries.
- Syngene International: Bangalore-based CRO offering analytical method development, validation, and impurity testing for global pharma clients. Comparable as a direct competitor in pharmaceutical analytical services, though at significantly greater scale.
- Aragen Life Sciences (formerly GVK Biosciences): India-headquartered CRO offering analytical chemistry, method development, and impurity services for pharmaceutical clients. Directly comparable service portfolio in the Indian pharma testing market.
- Smithers: US-based specialist testing lab with strong extractables/leachables and pharmaceutical analytical services practice. Closest comparable in terms of niche specialization in E/L and packaging testing.
- Sai Life Sciences: India-headquartered CRO/CDMO providing analytical testing, method development, and impurity characterization services to pharmaceutical innovators and generics. Highly comparable service overlap in extractables/leachables and method validation.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
iTrace Pharmaceutical Solutions Private Limited social profiles
Digital presenceiTrace Pharmaceutical Solutions Private Limited compliance and trust
Trust signalCompliance3 records
iTrace Pharmaceutical Solutions Private Limited financial estimates
Financial estimateRevenue estimate
Valuation estimate
iTrace Pharmaceutical Solutions Private Limited leadership team
Management profileNumber of profiles
Profiles3 records
iTrace Pharmaceutical Solutions Private Limited funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iTrace Pharmaceutical Solutions Private Limited M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iTrace Pharmaceutical Solutions Private Limited
What does iTrace Pharmaceutical Solutions Private Limited do?
iTrace Pharmaceutical Solutions operates an analytical chemistry testing laboratory serving pharmaceutical companies with specialized regulated studies. Its core offerings include extractables and leachables testing (per USP, PQRI, and BPOG), nitrosamines impurity analysis, method development and validation, glass delamination testing, elemental impurity analysis per USP 232/233, genotoxic impurity testing, medical device analysis per ISO 10993-17/18, and routine batch and stability testing. These services are delivered through advanced instrumentation (LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, UV) within a USFDA-registered, ISO 9001:2015-certified facility to support client submissions in regulated markets.
Is iTrace Pharmaceutical Solutions Private Limited a public or private company?
iTrace Pharmaceutical Solutions Private Limited is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was iTrace Pharmaceutical Solutions Private Limited founded?
iTrace Pharmaceutical Solutions Private Limited was founded in 2020. It employs 11 to 50 people.
Where is iTrace Pharmaceutical Solutions Private Limited based?
iTrace Pharmaceutical Solutions Private Limited is headquartered in Ambernath, India, in the Asia region.
How does iTrace Pharmaceutical Solutions Private Limited make money?
One revenue line is on record: laboratory Testing Services.
Who are iTrace Pharmaceutical Solutions Private Limited's main competitors?
Broad incumbents on record are WuXi AppTec, Intertek, SGS and Eurofins Scientific. Direct peers are Anthem Biosciences, Pace Analytical Services, Syngene International, Aragen Life Sciences (formerly GVK Biosciences), Smithers and Sai Life Sciences.
Does iTrace Pharmaceutical Solutions Private Limited have an API?
No public API is recorded for iTrace Pharmaceutical Solutions Private Limited.
What industry is iTrace Pharmaceutical Solutions Private Limited in?
iTrace Pharmaceutical Solutions Private Limited's product category is Pharmaceutical Analytical Testing Services. Its primary akta.pro industry code is HLAGADAI, Extractables & Leachables / Container-Closure Testing, with a secondary code of HLAGADAJ, Elemental Impurities & Trace Metals (ICP-MS). Its NAICS code is 541380 and its SIC code is 8734.